Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.26)
# 1,529
Out of 4,655 analysts
454
Total ratings
31.8%
Success rate
-12.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics | Reiterates: Buy | $22 | $11.14 | +97.49% | 17 | Nov 15, 2024 | |
| AVBP ArriVent BioPharma | Reiterates: Buy | $36 | $27.21 | +32.30% | 6 | Nov 15, 2024 | |
| CRGX CARGO Therapeutics | Reiterates: Buy | $33 | $16.00 | +106.25% | 3 | Nov 15, 2024 | |
| CRBU Caribou Biosciences | Reiterates: Buy | $9 | $1.99 | +352.26% | 12 | Nov 15, 2024 | |
| REPL Replimune Group | Reiterates: Buy | $17 | $10.80 | +57.41% | 13 | Nov 12, 2024 | |
| SWTX SpringWorks Therapeutics | Maintains: Buy | $76 → $74 | $36.45 | +103.02% | 28 | Nov 12, 2024 | |
| OKUR OnKure Therapeutics | Reiterates: Buy | $40 | $16.60 | +140.96% | 2 | Nov 8, 2024 | |
| TNGX Tango Therapeutics | Reiterates: Buy | $13 | $3.85 | +237.66% | 11 | Nov 8, 2024 | |
| RLAY Relay Therapeutics | Maintains: Buy | $19 → $20 | $5.11 | +291.77% | 18 | Nov 8, 2024 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $9 | $2.27 | +296.48% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.04 | +380.77% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.11 | +221.54% | 17 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $64 | $55.13 | +16.09% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $3.57 | +12.04% | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.62 | +319.85% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $8.50 | +147.06% | 17 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $8.90 | +91.01% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $12 | $15.39 | -22.03% | 18 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $30 | $22.92 | +30.89% | 12 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $150 | $99.72 | +50.42% | 36 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.59 | +340.25% | 5 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $24.41 | +51.58% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $34.45 | -15.82% | 3 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.63 | +166.16% | 11 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $9.47 | +16.16% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.48 | +82.48% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.11 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $12.00 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.61 | +210.56% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.85 | +164.71% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $0.83 | +1,348.58% | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.39 | +234.73% | 18 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.10 | +1,985.51% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.15 | +2,549.01% | 8 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $2.19 | +813.24% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.09 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.92 | +5,036.99% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.69 | +1,201.78% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $2.02 | +246.53% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $0.91 | +1,108.79% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $1.49 | +15,000.67% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $5.33 | +369.04% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $3.08 | +322.08% | 1 | Jan 7, 2021 |
Y-mAbs Therapeutics
Nov 15, 2024
Reiterates: Buy
Price Target: $22
Current: $11.14
Upside: +97.49%
ArriVent BioPharma
Nov 15, 2024
Reiterates: Buy
Price Target: $36
Current: $27.21
Upside: +32.30%
CARGO Therapeutics
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $16.00
Upside: +106.25%
Caribou Biosciences
Nov 15, 2024
Reiterates: Buy
Price Target: $9
Current: $1.99
Upside: +352.26%
Replimune Group
Nov 12, 2024
Reiterates: Buy
Price Target: $17
Current: $10.80
Upside: +57.41%
SpringWorks Therapeutics
Nov 12, 2024
Maintains: Buy
Price Target: $76 → $74
Current: $36.45
Upside: +103.02%
OnKure Therapeutics
Nov 8, 2024
Reiterates: Buy
Price Target: $40
Current: $16.60
Upside: +140.96%
Tango Therapeutics
Nov 8, 2024
Reiterates: Buy
Price Target: $13
Current: $3.85
Upside: +237.66%
Relay Therapeutics
Nov 8, 2024
Maintains: Buy
Price Target: $19 → $20
Current: $5.11
Upside: +291.77%
Allogene Therapeutics
Nov 8, 2024
Reiterates: Buy
Price Target: $9
Current: $2.27
Upside: +296.48%
Nov 8, 2024
Reiterates: Buy
Price Target: $5
Current: $1.04
Upside: +380.77%
Nov 8, 2024
Reiterates: Buy
Price Target: $10
Current: $3.11
Upside: +221.54%
Nov 7, 2024
Maintains: Buy
Price Target: $62 → $64
Current: $55.13
Upside: +16.09%
Nov 6, 2024
Reiterates: Neutral
Price Target: $4
Current: $3.57
Upside: +12.04%
Nov 6, 2024
Reiterates: Buy
Price Target: $11
Current: $2.62
Upside: +319.85%
Nov 4, 2024
Reiterates: Buy
Price Target: $21
Current: $8.50
Upside: +147.06%
Nov 4, 2024
Reiterates: Buy
Price Target: $17
Current: $8.90
Upside: +91.01%
Nov 1, 2024
Reiterates: Neutral
Price Target: $12
Current: $15.39
Upside: -22.03%
Oct 21, 2024
Maintains: Buy
Price Target: $26 → $30
Current: $22.92
Upside: +30.89%
Oct 7, 2024
Maintains: Buy
Price Target: $113 → $150
Current: $99.72
Upside: +50.42%
Oct 3, 2024
Reiterates: Buy
Price Target: $7
Current: $1.59
Upside: +340.25%
Oct 1, 2024
Reiterates: Buy
Price Target: $37
Current: $24.41
Upside: +51.58%
Sep 18, 2024
Reiterates: Buy
Price Target: $29
Current: $34.45
Upside: -15.82%
Sep 16, 2024
Maintains: Buy
Price Target: $8 → $7
Current: $2.63
Upside: +166.16%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $9.47
Upside: +16.16%
Aug 23, 2024
Reiterates: Buy
Price Target: $10
Current: $5.48
Upside: +82.48%
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.11
Upside: -
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $12.00
Upside: -
Aug 20, 2024
Reiterates: Buy
Price Target: $5
Current: $1.61
Upside: +210.56%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.85
Upside: +164.71%
Aug 15, 2024
Reiterates: Buy
Price Target: $12
Current: $0.83
Upside: +1,348.58%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $2.39
Upside: +234.73%
May 8, 2024
Maintains: Buy
Price Target: $5 → $2
Current: $0.10
Upside: +1,985.51%
Apr 16, 2024
Reiterates: Buy
Price Target: $4
Current: $0.15
Upside: +2,549.01%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $2.19
Upside: +813.24%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.09
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.92
Upside: +5,036.99%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.69
Upside: +1,201.78%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $2.02
Upside: +246.53%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $0.91
Upside: +1,108.79%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $1.49
Upside: +15,000.67%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $5.33
Upside: +369.04%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $3.08
Upside: +322.08%